AI Buyer Insights:

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Onco-Innovations Canada Data, Technology Stack, and Enterprise Applications
AI Development
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Kuano Legacy Kuano AI ML and Data Science Platforms AI Development n/a 2025 2025
In 2025 Onco-Innovations Canada engaged Kuano AI in a pilot collaboration to apply a quantum enabled AI platform to accelerate design and optimisation of PNKP inhibitors for drug discovery and R&D in Canada. The Kuano AI deployment is positioned within ML and Data Science Platforms and targets delivery of structural binding models, validated platform outputs and candidate compound designs as stated in the collaboration announcement. The implementation focuses on Kuano AI functional capabilities, inferred from the press release to include Kuano quantum molecular modelling branded Quantum Lens and generative AI compound design capabilities. Configuration indicates an emphasis on quantum molecular modelling for binding prediction, generative compound enumeration for candidate design, and a validation pipeline to produce platform verified structural models suitable for experimental follow up. Operational scope for the pilot is concentrated in Onco-Innovations research and development workflows, specifically computational chemistry and medicinal chemistry decision processes supporting PNKP inhibitor technology development. The collaboration frames outputs from Kuano AI as inputs to experimental validation and candidate triage rather than production manufacturing or clinical systems. Governance for the pilot is organized around iterative validation cycles, model output review by cross functional scientific teams, and defined acceptance criteria for candidate designs prior to laboratory testing. The engagement is described as a research mode pilot with future expansion contingent on validation outcomes and platform performance.
Collaboration
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Microsoft Legacy Microsoft 365 Collaboration Collaboration n/a 2024 2024
Content Management
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Automattic Legacy WordPress Web Content Management Content Management n/a 2025 2025
Web Content Management Content Management 2025 2025
CRM
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Marketing Automation CRM 2025 2025
PaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Apps Development PaaS 2023 2023
IaaS
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Hosting and Computing Services IaaS 2021 2021
Application Hosting and Computing Services IaaS 2021 2021
Application Hosting and Computing Services IaaS 2024 2024
Cloud Storage IaaS 2025 2025
Content Delivery Network IaaS 2023 2023
Domain Name System (DNS) IaaS 2021 2021
Domain Name System (DNS) IaaS 2024 2024
Network Management and Monitoring IaaS 2021 2021
CyberSecurity
Vendor
Previous System
Application
Category
Market
VAR/SI
When
Live
Insight
Application Security (AppSec) CyberSecurity 2025 2025
Secure Sockets Layer (SSL) CyberSecurity 2023 2023
IT Decision Makers and Key Stakeholders at Onco-Innovations Canada
First Name Last Name Title Function Department Email Phone
No data found
Apps Being Evaluated by Onco-Innovations Canada Executives
Date Company Status Vendor Product Category Market
No data found
FAQ - APPS RUN THE WORLD Onco-Innovations Canada Technographics

Onco-Innovations Canada is a Life Sciences organization based in Canada, with around 10 employees and annual revenues of $1.0 million.

Onco-Innovations Canada operates a diverse technology stack with applications such as Kuano AI, Microsoft 365 and WordPress, covering areas like ML and Data Science Platforms, Collaboration and Web Content Management.

Onco-Innovations Canada has invested in cloud applications and AI-driven platforms to optimize efficiency and growth, collaborating with vendors such as Kuano, Microsoft and Automattic.

Onco-Innovations Canada recently adopted applications including Kuano AI in 2025, WordPress in 2025 and Framer in 2025, highlighting its ongoing modernization strategy.

APPS RUN THE WORLD maintains an up-to-date database of Onco-Innovations Canada’s key decision makers and IT executives, available to Premium subscribers.

Our research team continuously updates Onco-Innovations Canada’s profile with verified software purchases, vendor relationships, and digital initiatives identified from public and proprietary sources.

Subscribe to APPS RUN THE WORLD to access the complete Onco-Innovations Canada technographics profile, including detailed breakdowns by category, vendor, and IT decision makers.